Document is current

Any future updates will be listed below

Safety and pharmacokinetics of FCN-437c, a novel cyclin-dependent kinase 4/6 inhibitor, in Chinese patients with hepatic impairment

Crossref DOI link: https://doi.org/10.1007/s10637-025-01552-5

Published Online: 2025-07-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark